Millis, MA, United States of America

Hamid Tissire

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Visterra, Inc.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hamid Tissire. Retrieved from https://idiyas.com/inventor/hamid-tissire-u7ilk2lv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hamid Tissire: Innovator in Antibody Molecule-Drug Conjugates

Introduction

Hamid Tissire is a notable inventor based in Millis, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibody molecule-drug conjugates.

Latest Patents

Hamid Tissire holds a patent for "Antibody molecule-drug conjugates and uses thereof." This patent describes antibody molecule-drug conjugates (ADCs) that specifically bind to lipopolysaccharides (LPS). These innovative conjugates can be utilized to treat, prevent, and diagnose bacterial infections and related disorders. He has 1 patent to his name.

Career Highlights

Tissire is currently employed at Visterra, Inc., where he continues to advance research in the field of antibody-drug conjugates. His work is pivotal in developing new therapeutic strategies for combating bacterial infections.

Collaborations

Some of his notable coworkers include Karthik Viswanathan and Kenneth Douglas Johnson. Their collaborative efforts contribute to the innovative environment at Visterra, Inc.

Conclusion

Hamid Tissire's work in antibody molecule-drug conjugates represents a significant advancement in medical science. His contributions are essential for the development of new treatments for bacterial infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…